Brainomix Limited
Brainomix is an AI-driven medical imaging company spun out from the University of Oxford, specializing in automated imaging biomarkers to improve diagnosis and treatment decisions in stroke, lung fibrosis, and cancer. Their flagship Brainomix 360 Stroke platform is the most comprehensive AI-powered stroke imaging solution globally, trusted by healthcare systems to enhance patient outcomes by enabling faster, more accurate stroke assessment and treatment decisions. The company is expanding its AI technology into other therapeutic areas with unmet needs, leveraging partnerships and FDA clearances to scale internationally, particularly in the US and Europe. Brainomix operates a SaaS business model, delivering AI software solutions that integrate into clinical workflows to support healthcare providers and clinical trials, with a strong focus on scientific validation and regulatory compliance.
Brainomix Limited
Brainomix is an AI-driven medical imaging company spun out from the University of Oxford, specializing in automated imaging biomarkers to improve diagnosis and treatment decisions in stroke, lung fibrosis, and cancer. Their flagship Brainomix 360 Stroke platform is the most comprehensive AI-powered stroke imaging solution globally, trusted by healthcare systems to enhance patient outcomes by enabling faster, more accurate stroke assessment and treatment decisions. The company is expanding its AI technology into other therapeutic areas with unmet needs, leveraging partnerships and FDA clearances to scale internationally, particularly in the US and Europe. Brainomix operates a SaaS business model, delivering AI software solutions that integrate into clinical workflows to support healthcare providers and clinical trials, with a strong focus on scientific validation and regulatory compliance.
